<?xml version="1.0" encoding="UTF-8"?>
<p>Due to the limited available publications on COVID-19, some publications and research articles that have been searching for SARS-CoV inhibitors can represent a good starting point to identify the competency antiviral agents against SARS-CoV-2. Therefore, it is necessary to review the antiviral agents that were successful in inhibiting this viral strain and the possibility of their effectiveness against this novel coronavirus. The primary sites of antiviral drug action are clarified in 
 <xref ref-type="fig" rid="F3">Figure 3</xref>.
</p>
